268 related articles for article (PubMed ID: 16567686)
1. Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis.
Hiraki T; Sakurai J; Gobara H; Kawamoto H; Mukai T; Hase S; Iguchi T; Fujiwara H; Tajiri N; Shiratori Y; Kanazawa S
J Vasc Interv Radiol; 2006 Mar; 17(3):583-5. PubMed ID: 16567686
[No Abstract] [Full Text] [Related]
2. Hepatobiliary and Pancreatic: Obstructive jaundice after transarterial chemoembolization of hepatocellular carcinoma related to intraductal tumor necrotic fragment.
Hwang HE; Tseng HS; Liu CA; Chiou YY; Yeh YC; Chiu NC
J Gastroenterol Hepatol; 2017 Mar; 32(3):546. PubMed ID: 28320063
[No Abstract] [Full Text] [Related]
3. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
4. Comments on "Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?".
Lee MW
Radiology; 2010 Feb; 254(2):633; author reply 634. PubMed ID: 20093536
[No Abstract] [Full Text] [Related]
5. Without victory there is no survival: transarterial lipiodol chemoembolization and hepatocellular carcinoma.
Sudan D; Sudan R; Schafer D; Langnas A
Hepatology; 1998 Jul; 28(1):270-1. PubMed ID: 9657124
[No Abstract] [Full Text] [Related]
6. Delayed anoxic pseudolobular necrosis (terminal hepatic necrosis) after chemo-lipiodolization for hepatocellular carcinoma.
Kozakai I; Ichida T; Yamaguchi O; Asakura H
Am J Gastroenterol; 1996 Jun; 91(6):1263-5. PubMed ID: 8651187
[No Abstract] [Full Text] [Related]
7. Tumor fragment impacted at the major duodenal papilla causing obstructive jaundice in a patient with hepatocellular carcinoma.
Kobayashi N; Kirikoshi H; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Yoneda K; Akiyama T; Fujita K; Yoneda M; Takahashi H; Abe Y; Inamori M; Kubota K; Saito S; Ueno N; Nakajima A
Gastrointest Endosc; 2008 Nov; 68(5):999-1000; discussion 1000. PubMed ID: 18640678
[No Abstract] [Full Text] [Related]
8. Cerebral lipiodol embolism: a complication of transcatheter arterial chemoembolization for hepatocellular carcinoma.
Matsumoto K; Nojiri J; Takase Y; Egashira Y; Azama S; Kato A; Kitahara K; Miyazaki K; Kudo S
Cardiovasc Intervent Radiol; 2007; 30(3):512-4. PubMed ID: 17171304
[TBL] [Abstract][Full Text] [Related]
9. Carbon dioxide-enhanced sonographically guided radiofrequency ablation combined with transcatheter arterial chemoembolization for sonographically undetectable hepatocellular carcinoma.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
Hepatogastroenterology; 2005; 52(65):1344-6. PubMed ID: 16201070
[TBL] [Abstract][Full Text] [Related]
10. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma.
Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D
Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962
[TBL] [Abstract][Full Text] [Related]
11. Stage IV hepatocellular carcinoma with portal venous tumor thrombus: complete response after combined therapy of repeated arterial chemoembolization and radiofrequency ablation.
Zheng RQ; Kudo M; Minami Y; Inui K; Chung H
J Gastroenterol; 2003; 38(4):406-9. PubMed ID: 12743785
[No Abstract] [Full Text] [Related]
12. [Effects of preoperative transcatheter artery chemoembolization on survival rate of hepatoma with percutaneous radiofrequency ablation].
Zhou DW; Zhang ZJ; Sun W
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):786-8. PubMed ID: 15949389
[No Abstract] [Full Text] [Related]
13. [Obstructive jaundice caused by hepatocellular carcinoma].
Nardello O; Farina GP; Cagetti M
Ann Ital Chir; 2005; 76(6):535-41. PubMed ID: 16821515
[TBL] [Abstract][Full Text] [Related]
14. Cholestatic hepatocellular carcinoma diagnosed by deposits of Lipiodol and treated by combination of endoscopic retrograde biliary drainage and transcatheter arterial embolization.
Shiina S; Komatsu Y; Kawabe T; Yoshiura K; Hamada E; Hata Y; Niwa Y; Kawase T; Ota S; Shiratori Y
J Gastroenterol Hepatol; 1992; 7(2):154-6. PubMed ID: 1315168
[TBL] [Abstract][Full Text] [Related]
15. [Interventional therapy for hepatocellular carcinoma].
Wang JH
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):721-3. PubMed ID: 16248940
[No Abstract] [Full Text] [Related]
16. [Ischemic cholecystitis caused by arterial chemoembolization of hepatocellular carcinoma].
De Diego A; Santos L; Vaquero J; Salcedo M; Ramos A; García Durán F; Rincón D; Cos E; Clemente G
Rev Esp Enferm Dig; 1999 Jan; 91(1):74-5. PubMed ID: 10089791
[No Abstract] [Full Text] [Related]
17. Transcatheter chemoembolization of unresectable hepatocellular carcinoma: current knowledge and future directions.
Maleux G; van Malenstein H; Vandecaveye V; Heye S; Vaninbroukx J; Nevens F; Verslype C
Dig Dis; 2009; 27(2):157-63. PubMed ID: 19546554
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter arterial chemoembolization in hepatocellular carcinoma: technique, effects and present status.
Paul SB; Guglani B; Gulati MS; Batra Y; Mukhopadhyay S
Trop Gastroenterol; 2003; 24(4):176-84. PubMed ID: 15164527
[No Abstract] [Full Text] [Related]
19. Delayed cerebral lipiodol embolism after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Wu JJ; Chao M; Zhang GQ; Li B
Chin Med J (Engl); 2009 Apr; 122(7):878-80. PubMed ID: 19493407
[No Abstract] [Full Text] [Related]
20. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
